PHVS vs REGN: Which Stock is Better?
Side-by-side comparison of Pharvaris Nv and Regeneron Pharmaceuticals Inc in 2026
PHVS
Pharvaris Nv
$28.78
REGN
Regeneron Pharmaceuticals Inc
$746.00
Key Metrics Comparison
| Metric | PHVS | REGN | Winner |
|---|---|---|---|
| Market Cap | $1.91B | $79.71B | REGN |
| P/E Ratio | N/A | 18.18 | REGN |
| EPS (TTM) | $N/A | $41.47 | REGN |
| Revenue Growth | 0.0% | 0.0% | REGN |
| Gross Margin | 0.0% | 44.6% | REGN |
Analyze PHVS
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHVS or REGN a better investment?
Comparing PHVS and REGN: Pharvaris Nv has a market cap of $1.91B while Regeneron Pharmaceuticals Inc has $79.71B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHVS and REGN?
PHVS (Pharvaris Nv) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHVS or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHVS or REGN?
REGN has higher revenue growth at 0.0% vs 0.0% for PHVS.
Which company is more profitable: PHVS or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for PHVS.
Which is the larger company: PHVS or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.71B compared to $1.91B for PHVS.
Should I buy PHVS or REGN in 2026?
Both PHVS and REGN have investment merit. PHVS trades at $28.78 while REGN trades at $746.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHVS and REGN stock?
Key differences: Market Cap ($1.91B vs $79.71B), P/E Ratio (N/A vs 18.2x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).